Domain Therapeutics

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

KyDo Therapeutics

This company develops covalent-allosteric small molecule inhibitors for the treatment of challenging cancer variants within the oncology sector.

T-Therapeutics

The company develops T cell receptor therapeutics and bispecific engagers for patients with cancer and autoimmune diseases.

Confo Therapeutics

Confo Therapeutics develops G-protein coupled receptor medicines for metabolic and endocrine diseases and provides drug discovery technology to global pharmaceutical companies.

Antag Therapeutics

This company develops GIP receptor antagonist therapies to treat patients living with obesity, type 2 diabetes and metabolic disorders.

Interax

This company develops a computational pharmacology platform to design and optimise drug candidates targeting G-protein-coupled receptors for biopharmaceutical partners.

Septerna, Inc

This biotechnology company develops small-molecule medicines targeting G protein-coupled receptors to treat patients with endocrine, inflammatory and metabolic diseases.

Enodia

This company develops small-molecule therapies that degrade disease-causing proteins at the point of synthesis for patients with cancer and inflammatory diseases.